← back to search

Sebastian Bender

Bayer (Germany) · DE
Area of research
Molecular Biology · Genetics
Research interest
Research interests include Glioma Diagnosis and Treatment, Neuroblastoma Research and Treatments, Epigenetics and DNA Methylation, and RNA modifications and cancer.
h-index
30
citations
13,021
works
131
NIH funding
primary concept
email

Recent publications

Proficiency Testing to Assess Technical Performance for CTC-Processing and Detection Methods in CANCER-ID
Clinical Chemistry 2020cited by 39position: middledoi
The landscape of genomic alterations across childhood cancers
Nature 2018cited by 1,589position: middledoi
Author Correction: The landscape of genomic alterations across childhood cancers
Nature 2018cited by 28position: middledoi
Dissecting telomere maintenance mechanisms in pediatric glioblastoma
bioRxiv (Cold Spring Harbor Laboratory) 2017cited by 6position: middledoi
Integrative Genome-Scale Analysis Identifies Epigenetic Mechanisms of Transcriptional Deregulation in Unfavorable Neuroblastomas
Cancer Research 2016cited by 125position: middledoi
Telomere dysfunction and chromothripsis
International Journal of Cancer 2016cited by 56position: middledoi
Low-dose Actinomycin-D treatment re-establishes the tumoursuppressive function of P53 in <i>RELA</i>-positive ependymoma
Oncotarget 2016cited by 30position: middledoi
Pediatric and Adult High-Grade Glioma Stem Cell Culture Models Are Permissive to Lytic Infection with Parvovirus H-1
Viruses 2016cited by 25position: middledoi
TB-17A COMPREHENSIVE PAN-CANCER ANALYSIS OF CHILDHOOD MALIGNANCIES
Neuro-Oncology 2016cited by 1position: middledoi
Integrated analysis of pediatric glioblastoma reveals a subset of biologically favorable tumors with associated molecular prognostic markers
Acta Neuropathologica 2015cited by 345position: middledoi
The <scp>tRNA</scp> methyltransferase Dnmt2 is required for accurate polypeptide synthesis during haematopoiesis
The EMBO Journal 2015cited by 232position: middledoi
Dynamic modulation of Dnmt2-dependent tRNA methylation by the micronutrient queuine
Nucleic Acids Research 2015cited by 119position: middledoi
Chronic Inflammation Induces a Novel Epigenetic Program That Is Conserved in Intestinal Adenomas and in Colorectal Cancer
Cancer Research 2015cited by 103position: middledoi
Cell culture models of pediatric high-grade glioma are susceptible to parvovirus-1 induced cytotoxicity
Klinische Pädiatrie 2015cited by 0position: middledoi
Genome Sequencing of SHH Medulloblastoma Predicts Genotype-Related Response to Smoothened Inhibition
Cancer Cell 2014cited by 778position: middledoi
Epigenomic alterations define lethal CIMP-positive ependymomas of infancy
Nature 2014cited by 621position: middledoi
Paediatric and adult glioblastoma: multiform (epi)genomic culprits emerge
Nature reviews. Cancer 2014cited by 559position: middledoi
p19-INK4d inhibits neuroblastoma cell growth, induces differentiation and is hypermethylated and downregulated in MYCN-amplified neuroblastomas
Human Molecular Genetics 2014cited by 22position: middledoi
Abstract 3094: Epigenetic classification of ependymal brain tumors across age groups
Cancer Research 2014cited by 0position: middledoi
Guanine Nucleotide-Binding Protein α Subunit Hypofunction in Children with Short Stature and Disproportionate Shortening of the 4th and 5th Metacarpals
Hormone Research in Paediatrics 2014cited by 0position: middledoi
Abstract 3084: Epigenetic deregulation in H3.3-K27M mutant pediatric high-grade gliomas
Cancer Research 2014cited by 0position: firstdoi
Reduced H3K27me3 and DNA Hypomethylation Are Major Drivers of Gene Expression in K27M Mutant Pediatric High-Grade Gliomas
Cancer Cell 2013cited by 838position: firstdoi
Recurrent somatic alterations of FGFR1 and NTRK2 in pilocytic astrocytoma
Nature Genetics 2013cited by 835position: middledoi
Oncolytic effects of parvovirus H‐1 in medulloblastoma are associated with repression of master regulators of early neurogenesis
International Journal of Cancer 2013cited by 26position: middledoi
Targeting H3.3 mutated pediatric high grade gliomas – A high throughput screening approach to identify novel therapeutic agents
Klinische Pädiatrie 2013cited by 0position: middledoi
Hotspot Mutations in H3F3A and IDH1 Define Distinct Epigenetic and Biological Subgroups of Glioblastoma
Cancer Cell 2012cited by 1,856position: middledoi
Dissecting the genomic complexity underlying medulloblastoma
Nature 2012cited by 875position: middledoi
Genome Sequencing of Pediatric Medulloblastoma Links Catastrophic DNA Rearrangements with TP53 Mutations
Cell 2012cited by 867position: middledoi
Dnmt3a Protects Active Chromosome Domains against Cancer-Associated Hypomethylation
PLoS Genetics 2012cited by 52position: middledoi
Abstract 1424: KCNJ2 comprises a marker of poor prognosis and a therapeutic target in non-WNT/non-SHH medulloblastoma
Cancer Research 2012cited by 1position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Stefan M. Pfister · Université du Québec11 papers (2013–2017)Peter Lichter · German Cancer Research Center9 papers (2012–2017)Olaf Witt · St. Jude Children's Research Hospital7 papers (2012–2016)David Jones · Mayo Clinic in Florida7 papers (2014–2017)Dominik Sturm · German Cancer Research Center5 papers (2013–2015)Andrey Korshunov · German Cancer Research Center5 papers (2012–2017)Marcel Kool · European Bioinformatics Institute5 papers (2014–2016)Till Milde · Children's Cancer Center4 papers (2012–2016)Frank Lyko · German Cancer Research Center4 papers (2012–2015)Jeannine Lacroix · Centre François Baclesse3 papers (2013–2016)Paul A. Northcott · Children's Research Hospital3 papers (2014–2016)Marc Zapatka · National Cancer Institute3 papers (2014–2016)Jean Rommelaere · German Cancer Research Center3 papers (2013–2016)Volker Hovestadt · Harvard University3 papers (2014–2016)Hendrik Witt · German Cancer Research Center3 papers (2012–2016)Barbara Leuchs · German Cancer Research Center3 papers (2013–2016)Kristian W. Pajtler · German Cancer Research Center2 papers (2016–2016)Daniel Dreidax · Hopp Children's Cancer Center Heidelberg2 papers (2014–2016)Günter Raddatz · German Cancer Research Center2 papers (2012–2015)R Josupeit · German Cancer Research Center2 papers (2015–2016)